CFS/ME: How Bloodwork Maps the Fatigue Biology

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Blood testing for CFS/ME maps stress hormones, inflammation, nutrient status, and protein reserves through cortisol, hs-CRP, vitamin D, and albumin. A flattened cortisol pattern—rather than the healthy morning peak (~5–25 µg/dL) with smooth decline—is associated with unrefreshing sleep, post-exertional crashes, and lightheadedness. Tracking these markers over time grounds symptoms in measurable biology and supports systems-based monitoring.

Read more →

Understand what your mental wellness results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

CFS/ME and the biology beneath the fatigue

CFS/ME biomarkers are measurable signals in blood and other tissues that capture how the illness disrupts core body systems. Instead of a single yes/no test, they map the biology behind symptoms—showing shifts in energy production, immune signaling, and automatic body regulation. In blood, these patterns can include altered immune messenger profiles (cytokines), changes in stress‑response rhythms (HPA axis), and metabolic fingerprints of cellular energy strain (mitochondrial oxidative metabolism). They can also reflect autonomic imbalance that drives lightheadedness, temperature swings, and unrefreshing sleep (dysautonomia). By translating invisible processes into objective numbers, biomarkers help validate symptoms like post‑exertional crash (post‑exertional malaise), guide exclusion of look‑alike conditions, and support research to define subtypes and targets for therapy. No single marker currently diagnoses ME/CFS on its own; the value lies in panels that track a consistent biological story over time. Used thoughtfully, biomarker testing turns lived experience into a biological map clinicians and researchers can act on.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why blood markers help map a multisystem illness

Blood tests in CFS/ME help map how the stress axis, immune system, nutrient status, and protein reserves are behaving across the whole body. Because CFS/ME is multisystem, objective biomarkers don’t diagnose it on their own, but they reveal patterns that explain fatigue, post‑exertional malaise, pain, sleep disturbance, and orthostatic symptoms—and they help rule out mimics. Cortisol normally peaks in the morning (about 5–25) and falls through the day; feeling best tends to align with a solid morning peak in the mid‑to‑upper normal range and a smooth decline. hs‑CRP reflects systemic inflammation; values near the low end are generally favorable. Vitamin D sufficiency commonly sits in the middle of the usual range (about 30–50). Albumin, a liver‑made carrier protein and oncotic “sponge,” is typically healthy in the mid‑to‑high normal range (about 3.5–5.0). When values run low, physiology shifts. A low or flattened morning cortisol suggests reduced HPA‑axis drive, often felt as unrefreshing sleep, “energy crashes,” worsened post‑exertional malaise, and lightheadedness on standing. Very low hs‑CRP means little systemic inflammation; in CFS/ME, symptoms can still stem from neuroimmune and autonomic dysregulation that CRP doesn’t capture. Low vitamin D impairs muscle function and bone turnover, adding diffuse aches and fatigue; in children/teens it can hinder bone accrual, and in pregnancy it impacts maternal‑fetal bone health. Low albumin points to inflammation, liver or renal loss, or poor intake/absorption, contributing to edema, weakness, and medication binding changes; in pregnancy, modest lowering can be physiologic hemodilution. Big picture: these markers anchor CFS/ME within the stress‑immune‑metabolic network, clarify comorbid risks (bone health, cardiometabolic inflammation, frailty), and support tracking over time as part of a comprehensive, systems‑based understanding.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

Where a blood panel helps and where it hits limits

Blood testing for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) provides a window into how the body’s core systems are functioning under stress. CFS/ME affects energy production, immune balance, inflammation, and the body’s ability to recover from daily demands. At Superpower, we focus on four key biomarkers—Cortisol, high-sensitivity C-reactive protein (hs-CRP), vitamin D, and albumin—to help map out these interconnected systems. Cortisol is the main stress hormone, reflecting how the body manages physical and emotional challenges. In CFS/ME, cortisol patterns can be disrupted, signaling altered stress response and energy regulation. hs-CRP is a sensitive marker of inflammation; even low-level increases can indicate ongoing immune activation, which is often seen in CFS/ME. Vitamin D is essential for immune modulation, muscle function, and overall vitality. Low levels are common in people with chronic fatigue and may reflect reduced sun exposure or altered metabolism. Albumin, a major blood protein, helps maintain fluid balance and transports hormones and nutrients. Lower albumin can signal chronic inflammation or poor nutritional status, both relevant in CFS/ME. Together, these biomarkers help assess the stability and resilience of the body’s stress response, inflammation control, and nutrient reserves. Balanced levels suggest the body is maintaining homeostasis, while persistent abnormalities may point to ongoing physiological strain in CFS/ME. Interpretation of these results depends on factors like age, sex, pregnancy, acute illness, medications, and laboratory methods. These variables can shift biomarker levels, so results are always considered in the context of the individual’s overall health and circumstances.

Frequently Asked Questions

References

  1. Maksoud R, Magawa C, Eaton-Fitch N, Thapaliya K, Marshall-Gradisnik S (2023). Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review. *BMC Medicine*, *21*(1), 189. https://doi.org/10.1186/s12916-023-02893-9
  2. Deumer US, Varesi A, Floris V, Savioli G, Mantovani E, Lopez-Carrasco P, Rosati GM, Prasad S, Ricevuti G (2021). Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): an overview. *Journal of Clinical Medicine*, *10*(20), 4786. https://doi.org/10.3390/jcm10204786
  3. Chu L, Valencia IJ, Garvert DW, Montoya JG (2018). Deconstructing post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: a patient-centered, cross-sectional survey. *PLoS ONE*, *13*(6), e0197811. https://doi.org/10.1371/journal.pone.0197811
  4. Holden S, Maksoud R, Eaton-Fitch N, Cabanas H, Staines D, Marshall-Gradisnik S (2020). A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease. *Journal of Translational Medicine*, *18*(1), 290. https://doi.org/10.1186/s12967-020-02452-3
  5. Wormgoor MEA, Rodenburg SC (2021). The evidence base for physiotherapy in myalgic encephalomyelitis/chronic fatigue syndrome when considering post-exertional malaise: a systematic review and narrative synthesis. *Journal of Translational Medicine*, *19*(1), 1. https://doi.org/10.1186/s12967-020-02683-4

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey